MMSIMERIT MEDICAL SYSTEMS INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $1.5B
- 12% YoY
- Operating margin
- 12.2%
- 6.2% YoY
- EBITDA
- $308M
- 19% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 0.8×
- $234M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear231% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear18% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | 12% |
| Operating income | $61M | $88M | $124M | $156M | $185M | 19% |
| Net income | $48M | $75M | $94M | $120M | $128M | 6.8% |
| Operating cash flow | $147M | $114M | $145M | $221M | $297M | 35% |
| Capex | $28M | $45M | $34M | $35M | $82M | 133% |
| Stock-based comp | $16M | $18M | $21M | $28M | $43M | 53% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.